Venturi Wealth Management LLC Has $220,000 Position in Tenet Healthcare Co. (NYSE:THC)

Venturi Wealth Management LLC increased its holdings in shares of Tenet Healthcare Co. (NYSE:THC) by 234.0% during the 4th quarter, Holdings Channel.com reports. The fund owned 1,740 shares of the company’s stock after acquiring an additional 1,219 shares during the period. Venturi Wealth Management LLC’s holdings in Tenet Healthcare were worth $220,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in THC. Creative Planning boosted its position in Tenet Healthcare by 2.9% in the third quarter. Creative Planning now owns 16,099 shares of the company’s stock valued at $2,676,000 after buying an additional 461 shares in the last quarter. Raymond James & Associates boosted its position in Tenet Healthcare by 24.9% in the third quarter. Raymond James & Associates now owns 130,485 shares of the company’s stock valued at $21,687,000 after buying an additional 26,011 shares in the last quarter. Signaturefd LLC boosted its position in Tenet Healthcare by 17.6% in the third quarter. Signaturefd LLC now owns 628 shares of the company’s stock valued at $104,000 after buying an additional 94 shares in the last quarter. International Assets Investment Management LLC boosted its position in Tenet Healthcare by 16,520.0% in the third quarter. International Assets Investment Management LLC now owns 18,282 shares of the company’s stock valued at $3,038,000 after buying an additional 18,172 shares in the last quarter. Finally, Legacy Capital Group California Inc. acquired a new position in Tenet Healthcare in the third quarter valued at about $1,055,000. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms have commented on THC. The Goldman Sachs Group lowered shares of Tenet Healthcare from a “buy” rating to a “neutral” rating and reduced their price target for the company from $196.00 to $140.00 in a research report on Monday, December 16th. Royal Bank of Canada upped their target price on shares of Tenet Healthcare from $174.00 to $183.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Barclays reduced their target price on shares of Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating on the stock in a research report on Thursday, February 13th. Wells Fargo & Company lowered shares of Tenet Healthcare from an “overweight” rating to an “equal weight” rating and reduced their target price for the stock from $205.00 to $150.00 in a research report on Monday, November 25th. Finally, StockNews.com lowered shares of Tenet Healthcare from a “buy” rating to a “hold” rating in a research report on Thursday, February 13th. Four equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $163.19.

Tenet Healthcare Stock Down 5.6 %

Shares of NYSE:THC opened at $129.57 on Friday. Tenet Healthcare Co. has a 52 week low of $88.98 and a 52 week high of $171.20. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.70 and a current ratio of 1.78. The company has a market capitalization of $12.32 billion, a PE ratio of 4.02, a PEG ratio of 1.01 and a beta of 2.05. The company has a 50 day moving average price of $132.90 and a two-hundred day moving average price of $147.69.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Wednesday, February 12th. The company reported $3.44 EPS for the quarter, beating the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. Analysts forecast that Tenet Healthcare Co. will post 12.24 earnings per share for the current year.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.